Search research articles
Contact Us
Filters
Showing results (201-210 of 226) with videos related to
Page
of 23
Sort By:
Cancers
|
June 19, 2024
A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy
Karan Dixit, Lauren Singer, Sean Aaron Grimm, et al.
Journal of the American Academy of Dermatology
|
February 5, 2015
The natural history of pediatric-onset discoid lupus erythematosus
Lisa M Arkin, Leah Ansell, Alfred Rademaker, et al.
Neurology
|
December 23, 2018
Word comprehension in temporal cortex and Wernicke area: A PPA perspective
M-Marsel Mesulam, Benjamin M Rader, Jaiashre Sridhar, et al.
Cancer Treatment and Research
|
September 19, 2009
Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancer
Andre T Baron, Jacqueline M Lafky, Cecelia H Boardman, et al.
Journal of the National Cancer Institute
|
October 21, 2004
Ductal lavage findings in women with known breast cancer undergoing mastectomy
Seema A Khan, Elizabeth L Wiley, Norma Rodriguez, et al.
Leukemia & Lymphoma
|
April 9, 2014
Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes
Olga Frankfurt, Shuo Ma, Leo Gordon, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 23, 2016
Glycemic Control Reduces Infections in Post-Liver Transplant Patients: Results of a Prospective, Randomized Study
Amisha Wallia, Kathleen Schmidt, Diana Johnson Oakes, et al.
Echocardiography (Mount Kisco, N.Y.)
|
November 10, 2019
Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia
Gregory J Cascino, Woo Bin Voss, Jonathan Canaani, et al.
British Journal of Haematology
|
April 27, 2007
G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis
Andrew M Evens, Jeffrey Cilley, Taylor Ortiz, et al.
Journal of Neuropathology and Experimental Neurology
|
March 28, 2018
Combined Pathologies in FTLD-TDP Types A and C
Tamar Gefen, Saman S Ahmadian, Qinwen Mao, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 226) with videos related to
Sort By:
Page
of 23
Cancers
|
June 19, 2024
A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy
Karan Dixit, Lauren Singer, Sean Aaron Grimm, et al.
Journal of the American Academy of Dermatology
|
February 5, 2015
The natural history of pediatric-onset discoid lupus erythematosus
Lisa M Arkin, Leah Ansell, Alfred Rademaker, et al.
Neurology
|
December 23, 2018
Word comprehension in temporal cortex and Wernicke area: A PPA perspective
M-Marsel Mesulam, Benjamin M Rader, Jaiashre Sridhar, et al.
Cancer Treatment and Research
|
September 19, 2009
Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancer
Andre T Baron, Jacqueline M Lafky, Cecelia H Boardman, et al.
Journal of the National Cancer Institute
|
October 21, 2004
Ductal lavage findings in women with known breast cancer undergoing mastectomy
Seema A Khan, Elizabeth L Wiley, Norma Rodriguez, et al.
Leukemia & Lymphoma
|
April 9, 2014
Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes
Olga Frankfurt, Shuo Ma, Leo Gordon, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 23, 2016
Glycemic Control Reduces Infections in Post-Liver Transplant Patients: Results of a Prospective, Randomized Study
Amisha Wallia, Kathleen Schmidt, Diana Johnson Oakes, et al.
Echocardiography (Mount Kisco, N.Y.)
|
November 10, 2019
Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia
Gregory J Cascino, Woo Bin Voss, Jonathan Canaani, et al.
British Journal of Haematology
|
April 27, 2007
G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis
Andrew M Evens, Jeffrey Cilley, Taylor Ortiz, et al.
Journal of Neuropathology and Experimental Neurology
|
March 28, 2018
Combined Pathologies in FTLD-TDP Types A and C
Tamar Gefen, Saman S Ahmadian, Qinwen Mao, et al.
Page
of 23